Cortes-Puch I

References (4)

Title : Randomized, double-blind, phase 1a single-ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers - Schmidt_2024_Clin.Transl.Sci_17_e70033
Author(s) : Schmidt WK , Cortes-Puch I , McReynolds CB , Croston GE , Hwang SH , Yang J , Pedersen TL , Wagner KM , Pham TT , Hunt T , Hammock BD
Ref : Clin Transl Sci , 17 :e70033 , 2024
Abstract :
PubMedSearch : Schmidt_2024_Clin.Transl.Sci_17_e70033
PubMedID: 39300734

Title : Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections - McReynolds_2021_Front.Physiol_12_663869
Author(s) : McReynolds CB , Cortes-Puch I , Ravindran R , Khan IH , Hammock BG , Shih PB , Hammock BD , Yang J
Ref : Front Physiol , 12 :663869 , 2021
Abstract :
PubMedSearch : McReynolds_2021_Front.Physiol_12_663869
PubMedID: 33868029

Title : Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative - Hammock_2021_J.Med.Chem__
Author(s) : Hammock BD , McReynolds CB , Wagner K , Buckpitt A , Cortes-Puch I , Croston G , Lee KSS , Yang J , Schmidt WK , Hwang SH
Ref : Journal of Medicinal Chemistry , : , 2021
Abstract :
PubMedSearch : Hammock_2021_J.Med.Chem__
PubMedID: 33550801

Title : Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19? - Panigrahy_2020_Cancer.Metastasis.Rev__
Author(s) : Panigrahy D , Gilligan MM , Huang S , Gartung A , Cortes-Puch I , Sime PJ , Phipps RP , Serhan CN , Hammock BD
Ref : Cancer Metastasis Rev , : , 2020
Abstract :
PubMedSearch : Panigrahy_2020_Cancer.Metastasis.Rev__
PubMedID: 32385712